Vaccination strategies for Korean patients with inflammatory bowel disease

Yoo Jin Lee, Eun Soo Kim

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Patients with inflammatory bowel disease (IBD) are vulnerable to vaccine-preventable may increase this vulnerability and attenuate vaccine efficacy. Thus, healthcare providers should understand infectious diseases and schedule vaccinations for them to reduce the infection-related burden of patients with IBD. All patients with IBD should be assessed in terms of immunity to vaccine-preventable diseases at the time of IBD diagnosis, and be vaccinated appropriately. Vaccination is becoming more important because of the unprecedented coronavirus disease 2019 (COVID-19) global health crisis. This review focuses on recent updates to vaccination strategies for Korean patients with IBD.

Original languageEnglish
Pages (from-to)920-930
Number of pages11
JournalKorean Journal of Internal Medicine
Volume37
Issue number5
DOIs
StatePublished - Sep 2022

Keywords

  • COVID-1
  • Inflammatory bowel diseases
  • Vaccination

Fingerprint

Dive into the research topics of 'Vaccination strategies for Korean patients with inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this